UN OCHA – Current Emergencies

UN OCHA – Current Emergencies
Current Corporate Emergencies
Afghanistan
No new updates identified.

Northern Ethiopia
No new updates identified.

Ukraine
Ukraine: Situation Report – Last updated: 19 May 2022
Eastern Ukraine remains the centre of hostilities, while airstrikes and missile attacks continue to be reported in multiple oblasts in Ukraine.
Humanitarian conditions deteriorate while needs grow, primarily in southern and eastern Ukraine, with wide-scale disruptions to electricity, gas and water supplies.
Municipal authorities and the World Health Organization warn of the potential outbreak of diseases, including cholera, in Mariupol due to unsanitary conditions.
As of 12 May, the UN and humanitarian partners have reached over 6.4 million people in need across Ukraine.
Over 5.7 million people received food assistance and 1.5 million health-related support from the UN and humanitarian partners since 24 February.

WHO & Regional Offices [to 21 May 2022]

WHO & Regional Offices [to 21 May 2022]
https://www.who.int/news
13 May 2022
Departmental news
WHO launches new Mortality Database visualization portal

13 May 2022
Departmental news
TB laboratory manuals issued to support the implementation of WHO-recommended diagnostics

12 May 2022
News release
WHO and MPP announce agreement with NIH for COVID-19 health technologies

12 May 2022
Departmental news
New report shows progress and missed opportunities in the control of NCDs at the national level

10 May 2022
Statement
World leaders urged to make firm commitments at Second Global COVID-19 Summit by ACT-Accelerator agency leads

::::::

WHO Director General Speeches [selected]
https://www.who.int/director-general/speeches
Selected
12 May 2022
Speech
WHO Deputy Director-General’s speech – Partnering to build sustainable Health Eco-System in Africa, African-European Collaboration

12 May 2022
Speech
WHO Director-General’s live speech at 2nd Global COVID Summit – 12 May 2022

10 May 2022
Speech
WHO Director-General’s remarks at the Special Session of the WHO Regional Committee for Europe — 10 May 2022

10 May 2022
Speech
WHO Director-General’s opening remarks at the WHO press conference – 10 May 2022

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region
:: Southern Africa faces uptick in COVID-19 cases
12 May 2022 Brazzaville – Southern Africa is facing an upsurge in COVID-19 cases for the third consecutive week as the winter season in the region approaches. The uptick has broken a two-month-long decline in overall infections recorded across the continent.
The sub-region recorded 46 271 cases in the week ending on 8 May 2022, marking a 32% increase over the week before.

WHO Region of the Americas PAHO
:: 10 May 2022 Technical Note: acute, severe hepatitis of unknown origin in children
This technical note follows the previous reports regarding the event of acute, severe hepatitis of unknown origin in children disseminated by the Pan American Health Organization / World Health Organization (PAHO/WHO) on 23 April 2022 (two reports), 25 April 2022, and 29 April 2022. This event was first reported by the United Kingdom…

WHO South-East Asia Region SEARO
No new digest content identified.

WHO European Region EURO
:: Two million confirmed deaths from COVID-19 in the European Region 12-05-2022
:: Setting up a behavioural insights unit – WHO launches a set of considerations to support countries 12-05-2022
:: “What stays with me is the feeling of helplessness” – on International Nurses Day, a young nurse recalls her time on a COVID-19 ward at the beginning of the pandemic 12-05-2022

WHO Eastern Mediterranean Region EMRO
:: Palestinian Ministry of Health launches polio vaccination campaign to boost immunity in Bethlehem and Jerusalem 13 May 2022
:: Somalia launches WHO emergency health response plan for drought 11 May 2022
:: Environmental surveillance for poliovirus introduced in Iraq 10 May 2022

WHO Western Pacific Region
No new digest content identified.

 

::::::

Disease Outbreak News (DONs)
Latest WHO Disease Outbreak News (DONs), providing information on confirmed acute public health events or potential events of concern.

13 May 2022 | Lassa fever – Guinea

12 May 2022 | Middle East respiratory syndrome coronavirus (MERS-CoV) – Qatar

9 May 2022 | Avian Influenza A(H3N8) – China

 

::::::

WHO Events
https://www.who.int/news-room/events/1
[Selected]
Seventy-fifth World Health Assembly WHA 75
22-28 May 2022
:: Provisional agenda A75/1 Rev.1
[See Milestones above]

 

::::::

New WHO Publications
https://www.who.int/publications/i
Selected Titles
20 May 2022
Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022

19 May 2022
Emergency in Ukraine: external situation report #12, published 19 May 2022: reporting period: 12–18 May…

19 May 2022
Background document on the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19

19 May 2022
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against…

19 May 2022
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19

18 May 2022
WHO information note on ensuring continuity of essential tuberculosis services for people with or at…

18 May 2022
Report of the second meeting of the WHO Technical Advisory Group on Diabetes: virtual meeting, 16–17…

18 May 2022
WHO Strategic Priorities on Antimicrobial Resistance

18 May 2022
Report of the first meeting of the WHO global diabetes compact forum: virtual meeting, 10–11 November…

18 May 2022
Stronger collaboration for an equitable and resilient recovery towards the health-related Sustainable…

17 May 2022
National workforce capacity to implement the essential public health functions including a focus on emergency…

17 May 2022
A Healthy Return
[See Perspectives above for detail]

17 May 2022
Implementation of the Initiative for coordinated antidotes procurement in the South-East Asia Region…

16 May 2022
HIV self-testing at workplaces: approaches to implementation and sustainable financing

16 May 2022
WHO Procurement Report 2021

15 May 2022
Global Report on Assistive Technology
Overview
There is a large, unmet need for assistive technology worldwide. The Global Report on Assistive Technology was developed in response to the World Health Assembly resolution (WHA71.8) on improving access to assistive technology adopted in May 2018. The Global Report is expected to play an instrumental role in setting the global roadmap for improving access to assistive technology for everyone, everywhere.

The Global Report on Assistive Technology presents a comprehensive dataset and analysis of current assistive technology access, drawing the attention of governments and civil society to the need for, and benefit of, assistive technology, including its return on investment. The Global Report sets out ten recommendations for improving access to assistive technology, which in turn support the achievement of the Sustainable Development Goals, inclusive Universal Health Coverage, and alignment with the Convention on the Rights of Persons with Disabilities.

Guided by an Expert Advisory Group, the WHO and UNICEF have jointly developed this report in the context of an integrated approach, based on the best available scientific evidence and international experience, in collaboration with stakeholders from diverse settings, multiple countries, and all regions. It is primarily directed at policy-makers, providers of assistive technology, donors and funding agencies, and industry leaders. It is also aimed at broader stakeholders including users and potential users of assistive technology and their families or caregivers.

13 May 2022
Practical manual of processing stool samples for diagnosis of childhood TB

13 May 2022
Line probe assays for detection of drug-resistant tuberculosis: interpretation and reporting manual for…

13 May 2022
Vaccines against influenza: WHO position paper – May 2022

13 May 2022
WHO advisory committee on variola virus research: report of the twenty-third meeting, virtual meeting,…

Coronavirus Disease 2019 (COVID-19)- CDC

Coronavirus Disease 2019 (COVID-19)CDC

Approximately 15 announcements/reports/data summaries.

:: 5/21/22  Cases in the U.S.

:: 5/21/22  Overall US COVID-19 Vaccine Distribution and Administration Update as of Sat, 21 May 2022 06:00:00 EST

:: 5/20/22  COVID-19 Vaccine Recommendations for Children and Teens

What You Need to Know

CDC recommends everyone ages 5 years and older get vaccinated against COVID-19.

Everyone ages 12 years and older should also get a COVID-19 booster shot.

Currently, the Pfizer-BioNTech COVID-19 vaccine is the only vaccine authorized or approved for children ages 5 through 17 years. Children and teens need two doses of a Pfizer-BioNTech vaccine. Everyone ages 12 years and older should also get a booster shot

China CDC 

China CDC 

http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China  [to  21 May 2022]

http://en.nhc.gov.cn/

News

May 21: Daily briefing on novel coronavirus cases in China

   On May 20, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 201 new cases of confirmed infections.

National Medical Products Administration – PRC  [to  21 May 2022]

http://english.nmpa.gov.cn/

News

Chinese mainland reports 176 new local confirmed COVID-19 cases

2022-05-20

   The Chinese mainland on Thursday reported 176 locally-transmitted confirmed COVID-19 cases, of which 88 were in Shanghai, according to the National Health Commission’s report Friday.

CCDC Weekly Reports: Current Volume (4)

[Website not responding at inquiry]

Africa CDC [to 21 May 2022]

Africa CDC [to 21 May 2022]
http://www.africacdc.org/
News
Singapore and the African Union can digitally verify each other’s COVID-19 Vaccination Certificates from 23 May 2022
17 May 2022

Communiqué
Communique: West African High Level Vaccines Manufacturers Meeting
17 May 2022
[Excerpts]
We the stakeholders in Vaccines Manufacturing in the West Africa Region under the leadership of ECOWAS/WAHO and Africa CDC met in Accra, Ghana from May 10th to 11th, 2022 to discuss on how to collaborate to ensure the production and availability of quality, safe and efficacious vaccines in the region…

The main objective of the high-level meeting is to create a framework for collaboration, information exchange and develop a framework for vaccines producers in the West African region to discuss strategically how to support each other build the regional hub for vaccines production.

Specifically, the meeting aims to:
Identify the bottlenecks in vaccines research and development and production.
Identify and define the types of vaccines to be produced for the region by each manufacturer.
Define short, medium, and long-term strategies to boost vaccines production in the region
Engage more partners and biotechnology developers to liaise with manufacturers…

Recommendations:
[1] The meeting agreed on types of vaccines to be produced in the region into considering that diversification of vaccines products (combining child immunization programs and adult vaccination programs that will require demand generation) will also help support manufacturers.

 

This includes twenty-two (22) identified vaccines which were further divided into 3 based on current and planned vaccine manufacturer’s capacities and capabilities in s terms of short-term, medium-term and long-term depending on the period of production.

Short term: Yellow Fever vaccines, Anti snake serum, Covid-19 vaccines, Pentavalent, Rabies, Measles, Ebola, Typhoid, Lassa, Rotavirus, Tetanus and Polio Vaccines (IPV)- 2022 to 2024
Medium term: Human papillomavirus (HPV), Pneumococcal (PCV3), Polio Vaccine bOPV-4 (oral), Malaria, Measles MMR, BCG, HepB-Pediatric, Meningitis A and 2025 -2027
Long-term: Anti-cancer, 2028 to 2030…

REQUESTS:
Heads of Governments, Health Ministers, Ministers of Industries and relevant Ministries to help facilitate adoption of the recommendations of this meeting by providing stronger political commitment.
ECOWAS/WAHO to engage stakeholders, technical and financial partners to fund the vaccines manufacturing in the region.
That national vaccines manufacturing plans are aligned with the regional and continental plans to prevent duplication of efforts.
ECOWAS/WAHO to follow up with stakeholders to ensure that the regional priorities are achieved.

Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

Airfinity [to 21 May 2022]

Organization Announcements

Editor’s Note:

Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

 

Airfinity    [to  21 May 2022]

https://www.airfinity.com/insights

INSIGHTS & COMPANY NEWS

No new digest content identified.

 

 

Paul G. Allen Frontiers Group    [to  21 May 2022]

https://alleninstitute.org/news-press/

News

No new digest content identified.

 

 

BMGF – Gates Foundation  [to  21 May 2022]

https://www.gatesfoundation.org/ideas/media-center

Press Releases and Statements

No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute    [to  21 May 2022]

https://www.gatesmri.org/news

The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people

No new digest content identified.

CARB-X   [to  21 May 2022]

https://carb-x.org/

News

05.19.2022  |

U.S. government and Wellcome commit up to an additional US$370 million to CARB-X

After celebrating its five-year anniversary in 2021, CARB-X (part of Boston University) announces renewed support from the U.S. Department of Health and Human Services (HHS) and Wellcome Trust, a U.K.-based global charitable foundation. The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within HHS, will provide US$20 million initially and up to US$300 million over 10 years to support the existing portfolio and launch new funding rounds. Wellcome will provide up to US$70 million over three years as part of its continued commitment to address the escalating threat of drug-resistant infections. Initial funding of $355 million from both BARDA and Wellcome originally launched CARB-X in 2016, and the new funding announced today builds on the success of this international non-profit partnership.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation   [to  21 May 2022]

https://centerforvaccineethicsandpolicy.net/

News/Analysis/Statements

:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.

:: Informed Consent: A Monthly Review – May 2022 is now posted here

:: Genomic Medicine Governance, Ethics, Policy: A Quarterly Review – May 2022 is now posted here

CEPI – Coalition for Epidemic Preparedness Innovations  [to  21 May 2022]

http://cepi.net/

Latest News

20 May 2022

COVAX calls for urgent action to close vaccine equity gap

Partners issue joint statement as supply constraints ease but inequity persists

[See COVID Perspectives above for detail]

18 May 2022

Sabin Vaccine Institute receives up to $6.3 Million from CEPI for dose-optimising COVID-19 vaccine clinical trial

The research will allow us to understand if smaller doses of COVID-19 vaccines generate similar immune responses to full doses.

18 May 2022

CEPI and GHIT collaborate to advance the global fight against infectious diseases

MoU will strengthen collaboration between the two organizations, supporting both agencies to deliver on their missions.

DARPA – Defense Advanced Research Projects Agency [U.S.] [to  21 May 2022

https://www.darpa.mil/news

News

No new digest content identified.

Duke Global Health Innovation Center  [to  21 May 2022]

https://dukeghic.org/

Our Blog

No new digest content identified.

 

 

EDCTP    [to  21 May 2022]

http://www.edctp.org/

The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials

News

No new digest content identified.

 

Emory Vaccine Center    [to  21 May 2022]

http://www.vaccines.emory.edu/

Vaccine Center News

New Emory TB research center to help draw attention to an old but still deadly disease

April 28, 2022

European Vaccine Initiative  [to  21 May 2022]

http://www.euvaccine.eu/

Latest News, Events

No new digest content identified.

 

 

Evidence Aid   [to  21 May 2022]

Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.

http://www.evidenceaid.org/

National approaches to the vaccination of recently arrived migrants in Europe Added May 18, 2022

Screening migrants for infectious diseases in Europe Added May 16, 2022

https://evidenceaid.org/resource/mental-health-and-work-experiences-of-interpreters-in-the-mental-health-care-of-refugees/

Fondation Merieux  [to  21 May 2022]

http://www.fondation-merieux.org/

News, Events

Mérieux Foundation co-organized event

Pioneering Ebola Response

May 24, 2022 – Milken Institute School of Public Health

Register

Context – Symposium honoring Jean-Jacques Muyembe Tamfum

A model for local leadership to address emerging infectious disease Challenges and opportunities for future detection of pandemic threats

Tuesday, May 24, 2022 – 10:00 – 11:30 (EDT)

 

Gavi [to  21 May 2022]

https://www.gavi.org/

News Releases

19 May 2022

COVAX calls for urgent action to close vaccine equity gap

[See COVID Perspectives above for detail]

GHIT Fund   [to  21 May 2022]

https://www.ghitfund.org/newsroom/press

Press Releases

May 18, 2022

CEPI and GHIT collaborate to advance the global fight against infectious diseases

 

Global Fund  [to  21 May 2022]

https://www.theglobalfund.org/en/news/

News & Stories

20 May 2022

Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment

The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to  21 May 2022]

https://www.glopid-r.org/news/

News

No new digest content identified

Hilleman Laboratories   [to  21 May 2022]

http://www.hilleman-labs.org/

News & Insights

No new digest content identified

 

 

HHMI – Howard Hughes Medical Institute    [to  21 May 2022]

https://www.hhmi.org/news

Press Room

Research   May 181 2022

Spying on Thousands of Neurons in the Brain’s Vision Center Simultaneously

Neurons across eight areas of the brain team up to process visual information. Researchers have now documented these neurons’ activity at a breadth and resolution never before reported.

 

 

Human Vaccines Project   [to  21 May 2022]

http://www.humanvaccinesproject.org/

News

No new digest content identified.

 

 

IAVI  [to  21 May 2022]

https://www.iavi.org/

Latest News

FEATURES

May 18, 2022

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity

May 17, 2022

HVAD 2022: An HIV vaccine developed with the people it seeks to benefit most

On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.

 

 

ICRC  [to  21 May 2022]

https://www.icrc.org/en/whats-new

What’s New   [Selected]

African Union and ICRC Marks 30 years of Partnership on Humanitarian Issues

20-05-2022 | Statement

COVID-19: People living in conflict zones cannot be forgotten in global vaccination effort

People living in warzones are at risk of being the very last in the world to have access to COVID-19 vaccines.

18-05-2022 | News release

[See COVID Perspectives above for detail]

COVID-19 Vaccination: Support to people affected by armed conflict and violence and those living in hard-to-reach areas

The ICRC is working with Red Cross and Red Crescent partners around the world to support COVID-19 vaccination in armed conflicts as well as hard-to-reach and volatile areas.

17-05-2022 | Article

[See COVID Perspectives above for detail]

International Coalition of Medicines Regulatory Authorities [ICMRA]

http://www.icmra.info/drupal/en/news

Selected Statements, Press Releases, Research

No new digest content identified.

IFFIm

http://www.iffim.org/

Press Releases/Announcements

No new digest content identified.

IFRC   [to  21 May 2022]

http://media.ifrc.org/ifrc/news/press-releases/

Press Releases [Selected]

IFRC report: Goals for poverty reduction, decent work and closing inequality gap, stalled by COVID-19 in Latin America and the Caribbean

20/05/2022 | Press release

IFRC president: Ethnicity and nationality should not be deciding factors in saving lives

16/05/2022 | Press release

Institut Pasteur   [to  21 May 2022]

https://www.pasteur.fr/en/press-area

Press Documents

Press release

18.05.2022

Phage Therapy: A Model to Predict Its Efficacy against Pathogenic Bacteria

Antibiotic resistance represents a major public health challenge, associated with a high mortality rate.

 

 

IOM / International Organization for Migration [to  21 May 2022]

http://www.iom.int/press-room/press-releases

News – Selected

20 May 2022

First United Nations Forum on International Migration Concludes Today

 

20 May 2022

Over 700,000 Affected by Cyclone Gombe in Mozambique Still in Need of Humanitarian Assistance as IOM Scales up Response

 

20 May 2022

Common Ground needed on Clear, Equitable Pandemic Travel Measures

…IOM Director General António Vitorino, MPI President Andrew Selee, and several participants voiced their support for the creation of a Member State-led Group of Friends to discuss cross-border mobility and pandemic preparedness, to complement and support the ongoing review of the International Health Regulations, and Member State negotiations towards a new pandemic treaty.

“Without this common endeavour, there is an increasing risk that future migration will become even more fragmented, accentuating the already evident signs of a two-speed recovery from COVID-19 that leaves less developed countries behind,” said DG Vitorino.

“This, in turn, will stall future economic and social development that could otherwise be accelerated through well-managed migration.”…

 

19 May 2022

Over 59 Million People Internally Displaced in 2021: IDMC Report

 

18 May 2022

IOM and UNICEF Sign New Strategic Collaboration Framework

ISC / International Science Council  [to  21 May 2022]

https://council.science/current/

ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.

Press releases

COVID-19 likely to worsen inequalities for at least five years without renewed global cooperation, warns International Science Council

16.05.2022

[See COVID Perspectives above for detail]

 

International Organization for Standardization (ISO)  [to 21 May 2022]

https://www.iso.org/news

News

New guidelines for COVID testing

11 May 2022

A new ISO technical specification will improve testing procedures and contribute to a safer world.

… Recently published, ISO/TS 5798 provides recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens…

International Union of Immunological Societies (IUIS)

https://iuis.org/

News/Events [Selected]

No new digest content identified.

IVAC  [to  21 May 2022]

https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html

Updates; Events

Webinar: Official Launch of the VERSE Equity Toolkit for Multidimensional Equity Assessments

Register Here

When: May 25, 2022 9:00 AM – 10:30 AM EST

Description: To identify what issues impair vaccine coverage, researchers traditionally look for an association with just one variable — wealth, for example — instead of examining the host of factors in play. Typical equity metrics may not appropriately account for the compounding effect of geographic and sociodemographic factors on immunization outcomes, such as, in the case of pediatric immunization, where a household is located, the sex of a child being vaccinated, and maternal education level. The VERSE Equity Toolkit compares the level of vaccine coverage against the level of equity and quantifies the influence of key sociodemographic factors to inequity.

 

 

IVI   [to  21 May 2022]

http://www.ivi.int/

IVI News & Announcements

No new digest content identified.

Johns Hopkins Center for Health Security   [to  21 May 2022]

https://www.centerforhealthsecurity.org/news/center-news/

Center News

No new digest content identified.

 

 

MSF/Médecins Sans Frontières  [to  21 May 2022]

http://www.msf.org/

Latest [Selected Announcements]

No new digest content identified.

National Academy of Medicine – USA  [to  21 May 2022]

https://nam.edu/programs/

News [Selected]

NAM Provides Opportunity for Public to Inform National Plan for Health Workforce Well-Being

May 20, 2022

Given the current shortage and burnout crisis faced by the health workforce, the National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience is working urgently to deliver a National Plan for health workforce well-being in June 2022, and today released a draft plan for public input. The National Plan intends to provide […]

National Academy of Sciences – USA  [to  21 May 2022]

http://www.nasonline.org/news-and-multimedia/

News

Improving Representation in Clinical Trials and Research – Building Research Equity for Women and Underrepresented Groups
National Academies of Sciences, Engineering, and Medicine (2022; 440 pages)
Lack of representation in research is compounding disparities in health outcomes with serious consequences for underrepresented groups and the nation as a whole. Urgent actions are needed by NIH FDA and others to boost representation of racial and ethnic minority groups and other underrepresented populations in clinical trials and research.

 

National Vaccine Program Office U.S. HHS  [to  21 May 2022]

https://www.hhs.gov/vaccines/about/index.html

Upcoming Meetings/Latest Updates                          

NVAC 2022 MeetingsJune 15-16, 2022

 

 

NIH  [to  21 May 2022]

http://www.nih.gov/

News Releases 

Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups

May 19, 2022 — Scientists used death certificate data to analyze age-adjusted cancer death rates.

Depression, loneliness associated with increased hospitalization risk after COVID-19, NIH-funded study suggests

May 19, 2022 — Scientists analyzed survey data from more than 54,000 female nurses and their children.

NIH announces antiviral drug development awards

May 18, 2022 — Scientists will seek to develop potential antivirals for COVID-19 and viral families with high potential to cause future pandemics.

Scientists identify characteristics to better define long COVID

May 16, 2022 — Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

Researchers identify the high costs of living with sickle cell disease

May 16, 2022 — Potential curative therapies may help reduce the burden, but are also costly.

 

Nuffield Council on Bioethics

https://www.nuffieldbioethics.org/news

News

17 May 2022

Ethics tools for decision-makers: Responding to public health threats

Throughout the COVID-19 pandemic, the Nuffield Council on Bioethics has consistently raised the importance of transparency in decision-making, especially the values that inform decisions.

Our latest publication ‘Ethics tools for decision-makers: Responding to public health threats‘ aims to help decision-makers with this. Drawing on our in-depth work on public health ethics, these tools explain what action decision-makers can take to develop a proportionate response to public health threats, guided by important public values such as reducing suffering, being fair and being respectful.

Summary

  • The state has responsibilities to enable people to live healthy lives and reduce health inequalities.
  • There are no easy answers, but responses to public health threats can be guided by the values of reducing suffering, treating people with respect, and fairness.
  • Options for public health interventions range from doing nothing to removing choice altogether.
  • Decision makers should aim for a proportionate response that takes into account the nature and degree of the harm posed, the certainty of the evidence, the intrusiveness of the intervention, and the views of those affected.
  • The application of each intervention is likely to generate further ethical questions and decision makers need to be alert to the need for transparency and accountability in decision making processes.

The tools include a version of our widely used ladder for public health interventions, adapted with examples for responding to COVID-19. Katharine Wright, lead author and Assistant Director of the Nuffield Council on Bioethics, said: “Public health threats such as COVID-19 are ethically challenging because they cannot be managed effectively by individuals alone, and any action taken will have broad and relatively indiscriminate impact. We believe looking at the problem through an ethics lens can help us reach good decisions about how to respond.”

PDF: https://www.nuffieldbioethics.org/assets/pdfs/Ethics-tools-for-decision-makers-FINAL1.pdf

 

 

OECD  [to  21 May 2022]

http://www.oecd.org/newsroom/publicationsdocuments/bydate/

Newsroom/Library

No new digest content identified.

 

PATH  [to  21 May 2022]

https://www.path.org/media-center/

Press Releases

No new digest content identified.

 

Rockefeller Foundation  [to 21 May 2022]

https://www.rockefellerfoundation.org/

Selected Reports/Press Releases

No new digest content identified.

Press Releases/

Global Energy Alliance for People and Planet and Sustainable Energy for All Announce Expanded Partnership to Tackle Energy Poverty Worldwide

05.18.22

$50 million commitment will support the scale-up of the Universal Energy Facility and advancement of countries’ energy access and transition plans

 

Sabin Vaccine Institute  [to  21 May 2022]

http://www.sabin.org/updates/pressreleases

Statements and Press Releases

Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial

Tuesday, May 17, 2022

WASHINGTON, D.C. –  The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to evaluate the immunogenicity and safety of lower, fractional doses of registered COVID-19 vaccines used as a booster dose. This dose optimizing trial will allow us to understand if smaller doses of COVID-19 vaccines generate similar immune responses to full doses. It will also provide key information as to whether lower doses may have fewer side effects, potentially increasing vaccine acceptance.

“This research has the potential to have the biggest impact in the places that need it the most,” said Amy Finan, CEO of the Sabin Vaccine Institute. “Just 1 in 6 people, 17.4%, have received a COVID-19 vaccine in low-income countries, compared to 72% in high income countries. There are currently sufficient global supplies of vaccine to meet demand, but that situation could change once again. The only way to end this pandemic is to ensure that everyone, everywhere has access to vaccines. That was Dr. Sabin’s goal during his lifetime, and it’s the goal now of the Sabin Vaccine Institute and this research.”…

UNAIDS [to  21 May 2022]

http://www.unaids.org/en

Selected Press Releases/Reports/Statements

20 May 2022

Helping Ukrainian refugees with HIV treatment and support in Berlin

17 May 2022

Unboxing self-esteem among transgender women in Brazil and their dreams for a dignified life

16 May 2022

Keeping LGBTI people safe in times of war

 

UNHCR Office of the United Nations High Commissioner for Refugees [to  21 May 2022]

http://www.unhcr.org/en-us/media-centre.htmlS

Selected News Releases, Announcements

UN High Commissioner for Refugees calls on states to lift remaining pandemic-related asylum restrictions

20 May 2022

[See Week in Review above for detail]

UN High Commissioner for Refugees Filippo Grandi’s message on the International Day Against Homophobia, Transphobia and Biphobia

17 May 2022

UNICEF  [to  21 May 2022]

https://www.unicef.org/media/press-releases

Press Releases, News Notes, Statements  [Selected]

Press release

18 May 2022

IOM and UNICEF sign new strategic collaboration framework

https://www.unicef.org/press-releases/iom-and-unicef-sign-new-strategic-collaboration-framework

NEW YORK, 18 May 2022 – The International Organization for Migration (IOM) and UNICEF today signed a new Strategic Collaboration Framework solidifying the organizations’ united commitment towards protecting the rights of migrant children. In 2006, UNICEF and IOM signed a Memorandum of Understanding defining the main areas of cooperation between…

Press release

18 May 2022

Landmark meeting urges prioritization of water and sanitation to get health, climate and economic targets back on track

https://www.unicef.org/press-releases/landmark-meeting-urges-prioritization-water-and-sanitation%E2%80%AF-get-health-climate-and

JAKARTA, 18 May 2022 – More than 350 participants from 57 countries gathered today in Jakarta for the opening of the Sector Ministers’ Meeting which will generate urgent prioritization of water and sanitation worldwide.    Among them were 50 ministers of water, sanitation, health, environment and the economy, who met to discuss the COVID-19…

Remarks

17 May 2022

UNICEF Executive Director Catherine Russell’s remarks at UN high-level event on conflict, hunger and children with Ambassador Linda Thomas-Greenfield of the United States

https://www.unicef.org/press-releases/unicef-executive-director-catherine-russells-remarks-un-high-level-event-conflict

NEW YORK, 17 May 2022 —  “Excellencies, Colleagues, Friends. “I am honored to welcome you to UNICEF House for this critical conversation.   “I want to acknowledge and thank the United States Government, and my co-host, United States Ambassador to the United Nations Linda Thomas-Greenfield, for putting children at the center of the discussion on…

Press release

16 May 2022

World a ‘virtual tinderbox’ for catastrophic levels of severe malnutrition in children

https://www.unicef.org/press-releases/world-virtual-tinderbox-catastrophic-levels-severe-malnutrition-children

NEW YORK, 17 May 2022 — The number of children with severe wasting was rising even before war in Ukraine threatened to plunge the world deeper into a spiralling global food crisis – and it’s getting worse, UNICEF warned in a new Child Alert. Released today, Severe wasting: An overlooked child survival emergency shows that in spite of rising levels…

Press release

16 May 2022

Almost one billion children and adults with disabilities and older persons in need of assistive technology denied access, according to new report

https://www.unicef.org/press-releases/almost-one-billion-children-and-adults-disabilities-and-older-persons-need-assistive

   GENEVA/NEW YORK, 16 May 2022 – A new report published today by WHO and UNICEF reveals that more than 2.5 billion people need one or more assistive products, such as wheelchairs, hearing aids, or apps that support communication and cognition. Yet nearly one billion of them are denied access, particularly in low- and middle-income countries, where…

 

Unitaid  [to  21 May 2022]

https://unitaid.org/

Featured News

19 May 2022

Unitaid marks 15th anniversary, celebrates greater equity in global health

19 May 2022

UN Secretary-General commends Unitaid’s commitment to health equity and innovation in advance of 15th anniversary

19 May 2022

Former US President Bill Clinton congratulates Unitaid on 15 years of life-saving work, in advance of anniversary event

16 May 2022

Portable thermal ablation devices allow more women to access lifesaving cervical cancer prevention in countries where the majority of deaths occur  

Vaccine Equity Cooperative [nee Initiative]   [to  21 May 2022]

https://vaccineequitycooperative.org/news/

News

No new digest content identified.

 

 

Vaccination Acceptance & Demand Initiative [Sabin)  [to  21 May 2022]

https://www.vaccineacceptance.org/

Announcements, Blog

No new digest content identified.

 

Vaccine Confidence Project  [to  21 May 2022]

http://www.vaccineconfidence.org/

News, Research and Reports

No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia  [to  21 May 2022]

http://www.chop.edu/centers-programs/vaccine-education-center

News

Vaccine Update for Providers

May 2022

  • Announcements: Misinterpreted science, new videos and essay contest reminder
  • News & views: COVID-19 death rates – Reality and conspiracies
  • In the journals: Underuse of convalescent plasma in treating COVID-19 led to excess deaths
  • Technically speaking: The hepatitis B midlife crisis
  • From the media: “With Kindness and Respect, We Can Help Others Choose to Be Vaccinated”
  • On the calendar: May is Hepatitis Awareness Month
  • On the bookshelf — Vaccinating Adults: A Step-by-Step Guide
  • Resources: COVID conversation guide, Public Health Law News, and “For Your Health News” project

Wellcome Trust  [to  21 May 2022]

https://wellcome.ac.uk/news

News. Opinion, Reports

No new digest content identified.

The Wistar Institute   [to  21 May 2022]

https://www.wistar.org/news/press-releases

Press Releases

No new digest content identified.

 

 

WFPHA: World Federation of Public Health Associations  [to  21 May 2022]

https://www.wfpha.org/

Latest News – Blog

Older Adults’ Vaccination: Why Is Vaccination Even More Crucial for the Most Vulnerable Subgroups?

May 19, 2022

 

World Bank [to  21 May 2022]

http://www.worldbank.org/en/news/all

Selected News, Announcements

World Bank Announces Planned Actions for Global Food Crisis Response

$30 billion available for implementation to address food insecurity over next 15 months WASHINGTON, May 18, 2022—The World Bank today announced actions it plans to take as part of a comprehensive, global…

Date: May 18, 2022 Type: Press Release

 

World Customs Organization – WCO  [to  21 May 2022]

http://www.wcoomd.org/

Latest News

17 May 2022

WCO Members of the Asia-Pacific region share lessons learnt from COVID-19 and discuss ways to enhance preparedness to tackle disruptive events

 

World Organisation for Animal Health (OIE)   [to  21 May 2022]

https://www.oie.int/en/

Press Releases, Statements

Egg prices on the rise: the effects of animal diseases

Editor’s Choice

16 May 2022

 

 

WTO – World Trade Organisation [to  21 May 2022]

http://www.wto.org/english/news_e/news_e.htm

WTO News and Events [Selected]

WTO virtual event looks at finance and trade lessons learned from COVID-19 pandemic

20 May 2022

A virtual event organized by the WTO on 20 May looked at the finance and trade lessons learned from the COVID-19 pandemic over the past two years. The event was attended by representatives and government officials from WTO members and observers with responsibilities relating to the implementation and negotiation of trade, intellectual property, finance and public health issues.

The event webpage, including access to the livestream, presentation and background materials, is available here: WTO | Finance and Trade Lessons from the Pandemic – Looking Forward.

 

::::::

 

ARM [Alliance for Regenerative Medicine]  [to  21 May 2022]

https://alliancerm.org/press-releases/

Selected Press Releases

No new digest content identified.

 

 

BIO    [to  21 May 2022]

https://www.bio.org/press-releases

Press Release

No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network  [to  21 May 2022]

http://www.dcvmn.org/

News; Upcoming events

No new digest content identified.

 

 

ICBA – International Council of Biotechnology Associations   [to  21 May 2022]

https://internationalbiotech.org/news/

News

No new digest content identified.

 

 

IFPMA   [to  21 May 2022]

http://www.ifpma.org/resources/news-releases/

Selected Press Releases, Statements, Publications

Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles

20 May 2022

As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient. We believe that patient populations in clinical trials should be reflective of the epidemiology and demographics of those who would benefit from the therapeutic agent. To this end, we believe that diversity and inclusion in clinical trials is a matter of both equity and scientific rigor and, as such, that all individuals should have equal opportunity to participate in relevant clinical trials. The biopharmaceutical industry is committed to take affirmative steps to increase clinical trial diversity.

PDF: https://www.ifpma.org/wp-content/uploads/2022/05/IFPMA-Global-Clinical-Trial-Diversity-Principles_May-19-2022-.pdf

 

International Alliance of Patients’ Organizations IAPO  [to  21 May 2022]

https://www.iapo.org.uk/news/topic/6

Press and media [Selected]

No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]

https://www.igbamedicines.org/

News

No new digest content identified.

 

 

PhRMA    [to  21 May 2022]

http://www.phrma.org/

Latest News [Selected]

No new digest content identified.

https://www.airfinity.com/insights
INSIGHTS & COMPANY NEWS
No new digest content identified.

Paul G. Allen Frontiers Group [to 21 May 2022]
https://alleninstitute.org/news-press/
News
No new digest content identified.

BMGF – Gates Foundation [to 21 May 2022]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 21 May 2022]
https://www.gatesmri.org/news
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 21 May 2022]

Home


News
05.19.2022 |
U.S. government and Wellcome commit up to an additional US$370 million to CARB-X
After celebrating its five-year anniversary in 2021, CARB-X (part of Boston University) announces renewed support from the U.S. Department of Health and Human Services (HHS) and Wellcome Trust, a U.K.-based global charitable foundation. The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within HHS, will provide US$20 million initially and up to US$300 million over 10 years to support the existing portfolio and launch new funding rounds. Wellcome will provide up to US$70 million over three years as part of its continued commitment to address the escalating threat of drug-resistant infections. Initial funding of $355 million from both BARDA and Wellcome originally launched CARB-X in 2016, and the new funding announced today builds on the success of this international non-profit partnership.

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 21 May 2022]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions of Vaccines and Global Health: The Week in Review are available here.
:: Informed Consent: A Monthly Review – May 2022 is now posted here
:: Genomic Medicine Governance, Ethics, Policy: A Quarterly Review – May 2022 is now posted here

CEPI – Coalition for Epidemic Preparedness Innovations [to 21 May 2022]

Home page


Latest News
20 May 2022
COVAX calls for urgent action to close vaccine equity gap
Partners issue joint statement as supply constraints ease but inequity persists
[See COVID Perspectives above for detail]

18 May 2022
Sabin Vaccine Institute receives up to $6.3 Million from CEPI for dose-optimising COVID-19 vaccine clinical trial
The research will allow us to understand if smaller doses of COVID-19 vaccines generate similar immune responses to full doses.

18 May 2022
CEPI and GHIT collaborate to advance the global fight against infectious diseases
MoU will strengthen collaboration between the two organizations, supporting both agencies to deliver on their missions.

DARPA – Defense Advanced Research Projects Agency [U.S.] [to 21 May 2022
https://www.darpa.mil/news
News
No new digest content identified.

Duke Global Health Innovation Center [to 21 May 2022]
https://dukeghic.org/
Our Blog
No new digest content identified.

EDCTP [to 21 May 2022]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
No new digest content identified.

Emory Vaccine Center [to 21 May 2022]
http://www.vaccines.emory.edu/
Vaccine Center News
New Emory TB research center to help draw attention to an old but still deadly disease
April 28, 2022

European Vaccine Initiative [to 21 May 2022]
http://www.euvaccine.eu/
Latest News, Events
No new digest content identified.

Evidence Aid [to 21 May 2022]
Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.
http://www.evidenceaid.org/
National approaches to the vaccination of recently arrived migrants in Europe Added May 18, 2022

Screening migrants for infectious diseases in Europe Added May 16, 2022

Mental health and work experiences of interpreters in the mental health care of refugees


Fondation Merieux [to 21 May 2022]

Accueil


News, Events
Mérieux Foundation co-organized event
Pioneering Ebola Response
May 24, 2022 – Milken Institute School of Public Health
Register
Context – Symposium honoring Jean-Jacques Muyembe Tamfum
A model for local leadership to address emerging infectious disease Challenges and opportunities for future detection of pandemic threats
Tuesday, May 24, 2022 – 10:00 – 11:30 (EDT)

Gavi [to 21 May 2022]
https://www.gavi.org/
News Releases
19 May 2022
COVAX calls for urgent action to close vaccine equity gap
[See COVID Perspectives above for detail]

GHIT Fund [to 21 May 2022]
https://www.ghitfund.org/newsroom/press
Press Releases
May 18, 2022
CEPI and GHIT collaborate to advance the global fight against infectious diseases

Global Fund [to 21 May 2022]
https://www.theglobalfund.org/en/news/
News & Stories
20 May 2022
Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment
The Global Fund has signed a letter of intent with Pfizer for the procurement of up to 6 million treatment courses of the new oral antiviral medicine nirmatrelvir/ritonavir, sold under the name PAXLOVID™, in 2022-2023.

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 21 May 2022]

Latest News


News
No new digest content identified

Hilleman Laboratories [to 21 May 2022]
http://www.hilleman-labs.org/
News & Insights
No new digest content identified

HHMI – Howard Hughes Medical Institute [to 21 May 2022]
https://www.hhmi.org/news
Press Room
Research May 181 2022
Spying on Thousands of Neurons in the Brain’s Vision Center Simultaneously
Neurons across eight areas of the brain team up to process visual information. Researchers have now documented these neurons’ activity at a breadth and resolution never before reported.

Human Vaccines Project [to 21 May 2022]
http://www.humanvaccinesproject.org/
News
No new digest content identified.

IAVI [to 21 May 2022]
https://www.iavi.org/
Latest News
FEATURES
May 18, 2022
IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity

May 17, 2022
HVAD 2022: An HIV vaccine developed with the people it seeks to benefit most
On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.

ICRC [to 21 May 2022]
https://www.icrc.org/en/whats-new
What’s New [Selected]
African Union and ICRC Marks 30 years of Partnership on Humanitarian Issues
20-05-2022 | Statement

COVID-19: People living in conflict zones cannot be forgotten in global vaccination effort
People living in warzones are at risk of being the very last in the world to have access to COVID-19 vaccines.
18-05-2022 | News release
[See COVID Perspectives above for detail]

COVID-19 Vaccination: Support to people affected by armed conflict and violence and those living in hard-to-reach areas
The ICRC is working with Red Cross and Red Crescent partners around the world to support COVID-19 vaccination in armed conflicts as well as hard-to-reach and volatile areas.
17-05-2022 | Article
[See COVID Perspectives above for detail]

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

IFRC [to 21 May 2022]
http://media.ifrc.org/ifrc/news/press-releases/
Press Releases [Selected]
IFRC report: Goals for poverty reduction, decent work and closing inequality gap, stalled by COVID-19 in Latin America and the Caribbean
20/05/2022 | Press release

IFRC president: Ethnicity and nationality should not be deciding factors in saving lives
16/05/2022 | Press release

Institut Pasteur [to 21 May 2022]
https://www.pasteur.fr/en/press-area
Press Documents
Press release
18.05.2022
Phage Therapy: A Model to Predict Its Efficacy against Pathogenic Bacteria
Antibiotic resistance represents a major public health challenge, associated with a high mortality rate.

IOM / International Organization for Migration [to 21 May 2022]
http://www.iom.int/press-room/press-releases
News – Selected
20 May 2022
First United Nations Forum on International Migration Concludes Today

20 May 2022
Over 700,000 Affected by Cyclone Gombe in Mozambique Still in Need of Humanitarian Assistance as IOM Scales up Response

20 May 2022
Common Ground needed on Clear, Equitable Pandemic Travel Measures
…IOM Director General António Vitorino, MPI President Andrew Selee, and several participants voiced their support for the creation of a Member State-led Group of Friends to discuss cross-border mobility and pandemic preparedness, to complement and support the ongoing review of the International Health Regulations, and Member State negotiations towards a new pandemic treaty.
“Without this common endeavour, there is an increasing risk that future migration will become even more fragmented, accentuating the already evident signs of a two-speed recovery from COVID-19 that leaves less developed countries behind,” said DG Vitorino.
“This, in turn, will stall future economic and social development that could otherwise be accelerated through well-managed migration.”…

19 May 2022
Over 59 Million People Internally Displaced in 2021: IDMC Report

18 May 2022
IOM and UNICEF Sign New Strategic Collaboration Framework

ISC / International Science Council [to 21 May 2022]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
Press releases
COVID-19 likely to worsen inequalities for at least five years without renewed global cooperation, warns International Science Council
16.05.2022
[See COVID Perspectives above for detail]

International Organization for Standardization (ISO) [to 21 May 2022]
https://www.iso.org/news
News
New guidelines for COVID testing
11 May 2022
A new ISO technical specification will improve testing procedures and contribute to a safer world.
… Recently published, ISO/TS 5798 provides recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens…

International Union of Immunological Societies (IUIS)
https://iuis.org/
News/Events [Selected]
No new digest content identified.

IVAC [to 21 May 2022]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Official Launch of the VERSE Equity Toolkit for Multidimensional Equity Assessments
Register Here
When: May 25, 2022 9:00 AM – 10:30 AM EST
Description: To identify what issues impair vaccine coverage, researchers traditionally look for an association with just one variable — wealth, for example — instead of examining the host of factors in play. Typical equity metrics may not appropriately account for the compounding effect of geographic and sociodemographic factors on immunization outcomes, such as, in the case of pediatric immunization, where a household is located, the sex of a child being vaccinated, and maternal education level. The VERSE Equity Toolkit compares the level of vaccine coverage against the level of equity and quantifies the influence of key sociodemographic factors to inequity.

IVI [to 21 May 2022]
http://www.ivi.int/
IVI News & Announcements
No new digest content identified.

Johns Hopkins Center for Health Security [to 21 May 2022]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.

MSF/Médecins Sans Frontières [to 21 May 2022]
http://www.msf.org/
Latest [Selected Announcements]
No new digest content identified.

National Academy of Medicine – USA [to 21 May 2022]
https://nam.edu/programs/
News [Selected]
NAM Provides Opportunity for Public to Inform National Plan for Health Workforce Well-Being
May 20, 2022
Given the current shortage and burnout crisis faced by the health workforce, the National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience is working urgently to deliver a National Plan for health workforce well-being in June 2022, and today released a draft plan for public input. The National Plan intends to provide […]

National Academy of Sciences – USA [to 21 May 2022]
http://www.nasonline.org/news-and-multimedia/
News
Improving Representation in Clinical Trials and Research – Building Research Equity for Women and Underrepresented Groups
National Academies of Sciences, Engineering, and Medicine (2022; 440 pages)
Lack of representation in research is compounding disparities in health outcomes with serious consequences for underrepresented groups and the nation as a whole. Urgent actions are needed by NIH FDA and others to boost representation of racial and ethnic minority groups and other underrepresented populations in clinical trials and research.

National Vaccine Program Office – U.S. HHS [to 21 May 2022]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
NVAC 2022 Meetings – June 15-16, 2022

NIH [to 21 May 2022]
http://www.nih.gov/
News Releases
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
May 19, 2022 — Scientists used death certificate data to analyze age-adjusted cancer death rates.

Depression, loneliness associated with increased hospitalization risk after COVID-19, NIH-funded study suggests
May 19, 2022 — Scientists analyzed survey data from more than 54,000 female nurses and their children.

NIH announces antiviral drug development awards
May 18, 2022 — Scientists will seek to develop potential antivirals for COVID-19 and viral families with high potential to cause future pandemics.

Scientists identify characteristics to better define long COVID
May 16, 2022 — Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.

Researchers identify the high costs of living with sickle cell disease
May 16, 2022 — Potential curative therapies may help reduce the burden, but are also costly.

Nuffield Council on Bioethics
https://www.nuffieldbioethics.org/news
News
17 May 2022
Ethics tools for decision-makers: Responding to public health threats
Throughout the COVID-19 pandemic, the Nuffield Council on Bioethics has consistently raised the importance of transparency in decision-making, especially the values that inform decisions.
Our latest publication ‘Ethics tools for decision-makers: Responding to public health threats’ aims to help decision-makers with this. Drawing on our in-depth work on public health ethics, these tools explain what action decision-makers can take to develop a proportionate response to public health threats, guided by important public values such as reducing suffering, being fair and being respectful.
Summary
– The state has responsibilities to enable people to live healthy lives and reduce health inequalities.
– There are no easy answers, but responses to public health threats can be guided by the values of reducing suffering, treating people with respect, and fairness.
– Options for public health interventions range from doing nothing to removing choice altogether.
– Decision makers should aim for a proportionate response that takes into account the nature and degree of the harm posed, the certainty of the evidence, the intrusiveness of the intervention, and the views of those affected.
– The application of each intervention is likely to generate further ethical questions and decision makers need to be alert to the need for transparency and accountability in decision making processes.
The tools include a version of our widely used ladder for public health interventions, adapted with examples for responding to COVID-19. Katharine Wright, lead author and Assistant Director of the Nuffield Council on Bioethics, said: “Public health threats such as COVID-19 are ethically challenging because they cannot be managed effectively by individuals alone, and any action taken will have broad and relatively indiscriminate impact. We believe looking at the problem through an ethics lens can help us reach good decisions about how to respond.”
PDF: https://www.nuffieldbioethics.org/assets/pdfs/Ethics-tools-for-decision-makers-FINAL1.pdf

OECD [to 21 May 2022]
http://www.oecd.org/newsroom/publicationsdocuments/bydate/
Newsroom/Library
No new digest content identified.

PATH [to 21 May 2022]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

Rockefeller Foundation [to 21 May 2022]

Home


Selected Reports/Press Releases
No new digest content identified.
Press Releases/
Global Energy Alliance for People and Planet and Sustainable Energy for All Announce Expanded Partnership to Tackle Energy Poverty Worldwide
05.18.22
$50 million commitment will support the scale-up of the Universal Energy Facility and advancement of countries’ energy access and transition plans

Sabin Vaccine Institute [to 21 May 2022]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Sabin Vaccine Institute Receives up to $6.3 Million from CEPI for Dose-Optimizing COVID-19 Vaccine Clinical Trial
Tuesday, May 17, 2022
WASHINGTON, D.C. – The Sabin Vaccine Institute was awarded up to $6.3 million from the Coalition for Epidemic Preparedness Innovations (CEPI) for a clinical trial to evaluate the immunogenicity and safety of lower, fractional doses of registered COVID-19 vaccines used as a booster dose. This dose optimizing trial will allow us to understand if smaller doses of COVID-19 vaccines generate similar immune responses to full doses. It will also provide key information as to whether lower doses may have fewer side effects, potentially increasing vaccine acceptance.
“This research has the potential to have the biggest impact in the places that need it the most,” said Amy Finan, CEO of the Sabin Vaccine Institute. “Just 1 in 6 people, 17.4%, have received a COVID-19 vaccine in low-income countries, compared to 72% in high income countries. There are currently sufficient global supplies of vaccine to meet demand, but that situation could change once again. The only way to end this pandemic is to ensure that everyone, everywhere has access to vaccines. That was Dr. Sabin’s goal during his lifetime, and it’s the goal now of the Sabin Vaccine Institute and this research.”…

UNAIDS [to 21 May 2022]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
20 May 2022
Helping Ukrainian refugees with HIV treatment and support in Berlin

17 May 2022
Unboxing self-esteem among transgender women in Brazil and their dreams for a dignified life

16 May 2022
Keeping LGBTI people safe in times of war

UNHCR Office of the United Nations High Commissioner for Refugees [to 21 May 2022]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
UN High Commissioner for Refugees calls on states to lift remaining pandemic-related asylum restrictions
20 May 2022
[See Week in Review above for detail]

UN High Commissioner for Refugees Filippo Grandi’s message on the International Day Against Homophobia, Transphobia and Biphobia
17 May 2022

UNICEF [to 21 May 2022]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Press release
18 May 2022
IOM and UNICEF sign new strategic collaboration framework
https://www.unicef.org/press-releases/iom-and-unicef-sign-new-strategic-collaboration-framework
NEW YORK, 18 May 2022 – The International Organization for Migration (IOM) and UNICEF today signed a new Strategic Collaboration Framework solidifying the organizations’ united commitment towards protecting the rights of migrant children. In 2006, UNICEF and IOM signed a Memorandum of Understanding defining the main areas of cooperation between…

Press release
18 May 2022
Landmark meeting urges prioritization of water and sanitation to get health, climate and economic targets back on track
https://www.unicef.org/press-releases/landmark-meeting-urges-prioritization-water-and-sanitation%E2%80%AF-get-health-climate-and
JAKARTA, 18 May 2022 – More than 350 participants from 57 countries gathered today in Jakarta for the opening of the Sector Ministers’ Meeting which will generate urgent prioritization of water and sanitation worldwide.   Among them were 50 ministers of water, sanitation, health, environment and the economy, who met to discuss the COVID-19…

Remarks
17 May 2022
UNICEF Executive Director Catherine Russell’s remarks at UN high-level event on conflict, hunger and children with Ambassador Linda Thomas-Greenfield of the United States
https://www.unicef.org/press-releases/unicef-executive-director-catherine-russells-remarks-un-high-level-event-conflict
NEW YORK, 17 May 2022 — “Excellencies, Colleagues, Friends. “I am honored to welcome you to UNICEF House for this critical conversation. “I want to acknowledge and thank the United States Government, and my co-host, United States Ambassador to the United Nations Linda Thomas-Greenfield, for putting children at the center of the discussion on…

Press release
16 May 2022
World a ‘virtual tinderbox’ for catastrophic levels of severe malnutrition in children
https://www.unicef.org/press-releases/world-virtual-tinderbox-catastrophic-levels-severe-malnutrition-children
NEW YORK, 17 May 2022 — The number of children with severe wasting was rising even before war in Ukraine threatened to plunge the world deeper into a spiralling global food crisis – and it’s getting worse, UNICEF warned in a new Child Alert. Released today, Severe wasting: An overlooked child survival emergency shows that in spite of rising levels…

Press release
16 May 2022
Almost one billion children and adults with disabilities and older persons in need of assistive technology denied access, according to new report
https://www.unicef.org/press-releases/almost-one-billion-children-and-adults-disabilities-and-older-persons-need-assistive
GENEVA/NEW YORK, 16 May 2022 – A new report published today by WHO and UNICEF reveals that more than 2.5 billion people need one or more assistive products, such as wheelchairs, hearing aids, or apps that support communication and cognition. Yet nearly one billion of them are denied access, particularly in low- and middle-income countries, where…

Unitaid [to 21 May 2022]
https://unitaid.org/
Featured News
19 May 2022
Unitaid marks 15th anniversary, celebrates greater equity in global health

19 May 2022
UN Secretary-General commends Unitaid’s commitment to health equity and innovation in advance of 15th anniversary

19 May 2022
Former US President Bill Clinton congratulates Unitaid on 15 years of life-saving work, in advance of anniversary event

16 May 2022
Portable thermal ablation devices allow more women to access lifesaving cervical cancer prevention in countries where the majority of deaths occur

Vaccine Equity Cooperative [nee Initiative] [to 21 May 2022]

News


News
No new digest content identified.

Vaccination Acceptance & Demand Initiative [Sabin) [to 21 May 2022]
https://www.vaccineacceptance.org/
Announcements, Blog
No new digest content identified.

Vaccine Confidence Project [to 21 May 2022]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia [to 21 May 2022]
http://www.chop.edu/centers-programs/vaccine-education-center
News
Vaccine Update for Providers
May 2022
– Announcements: Misinterpreted science, new videos and essay contest reminder
– News & views: COVID-19 death rates – Reality and conspiracies
– In the journals: Underuse of convalescent plasma in treating COVID-19 led to excess deaths
– Technically speaking: The hepatitis B midlife crisis
– From the media: “With Kindness and Respect, We Can Help Others Choose to Be Vaccinated”
– On the calendar: May is Hepatitis Awareness Month
– On the bookshelf — Vaccinating Adults: A Step-by-Step Guide
– Resources: COVID conversation guide, Public Health Law News, and “For Your Health News” project

Wellcome Trust [to 21 May 2022]
https://wellcome.ac.uk/news
News. Opinion, Reports
No new digest content identified.

The Wistar Institute [to 21 May 2022]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

WFPHA: World Federation of Public Health Associations [to 21 May 2022]

HOME


Latest News – Blog
Older Adults’ Vaccination: Why Is Vaccination Even More Crucial for the Most Vulnerable Subgroups?
May 19, 2022

World Bank [to 21 May 2022]
http://www.worldbank.org/en/news/all
Selected News, Announcements
World Bank Announces Planned Actions for Global Food Crisis Response
$30 billion available for implementation to address food insecurity over next 15 months WASHINGTON, May 18, 2022—The World Bank today announced actions it plans to take as part of a comprehensive, global…
Date: May 18, 2022 Type: Press Release

World Customs Organization – WCO [to 21 May 2022]
http://www.wcoomd.org/
Latest News
17 May 2022
WCO Members of the Asia-Pacific region share lessons learnt from COVID-19 and discuss ways to enhance preparedness to tackle disruptive events

World Organisation for Animal Health (OIE) [to 21 May 2022]
https://www.oie.int/en/
Press Releases, Statements
Egg prices on the rise: the effects of animal diseases
Editor’s Choice
16 May 2022

WTO – World Trade Organisation [to 21 May 2022]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events [Selected]
WTO virtual event looks at finance and trade lessons learned from COVID-19 pandemic
20 May 2022
A virtual event organized by the WTO on 20 May looked at the finance and trade lessons learned from the COVID-19 pandemic over the past two years. The event was attended by representatives and government officials from WTO members and observers with responsibilities relating to the implementation and negotiation of trade, intellectual property, finance and public health issues.
The event webpage, including access to the livestream, presentation and background materials, is available here: WTO | Finance and Trade Lessons from the Pandemic – Looking Forward.

::::::

ARM [Alliance for Regenerative Medicine] [to 21 May 2022]

Press Releases


Selected Press Releases
No new digest content identified.

BIO [to 21 May 2022]
https://www.bio.org/press-releases
Press Release
No new digest content identified.

DCVMN – Developing Country Vaccine Manufacturers Network [to 21 May 2022]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

ICBA – International Council of Biotechnology Associations [to 21 May 2022]
https://internationalbiotech.org/news/
News
No new digest content identified.

IFPMA [to 21 May 2022]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Diversity and Inclusion in Clinical Trials: Bioethical Perspective and Principles
20 May 2022
As IFPMA members, we believe that the knowledge gained from clinical trials should be used to support the development and use of innovative medicines, vaccines and other therapies, in order to develop the right treatment for the right patient. We believe that patient populations in clinical trials should be reflective of the epidemiology and demographics of those who would benefit from the therapeutic agent. To this end, we believe that diversity and inclusion in clinical trials is a matter of both equity and scientific rigor and, as such, that all individuals should have equal opportunity to participate in relevant clinical trials. The biopharmaceutical industry is committed to take affirmative steps to increase clinical trial diversity.
PDF: https://www.ifpma.org/wp-content/uploads/2022/05/IFPMA-Global-Clinical-Trial-Diversity-Principles_May-19-2022-.pdf

International Alliance of Patients’ Organizations – IAPO [to 21 May 2022]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

PhRMA [to 21 May 2022]
http://www.phrma.org/
Latest News [Selected]
No new digest content identified.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Health Equity in US Latinx Communities

AMA Journal of Ethics
Volume 24, Number 4: E249-341 Apr 2022
https://journalofethics.ama-assn.org/issue/health-equity-us-latinx-communities

 

Health Equity in US Latinx Communities
Latinx communities in the US include over 60 million people with a plurality of political beliefs, cultural practices, and wealth. This diversity is also expressed in population health data: some health indicators suggest advantages of Latinx community membership while other data demonstrate inequitable disease burden and maldistribution of environmental and occupational risk. Legacies of colonial conquest of the Americas persist in discrimination and marginalization today and are embodied by members of our Latinx communities.

The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil

American Journal of Infection Control
May 2022 Volume 50 Issue 5 p477-592
http://www.ajicjournal.org/current

 

Major Articles
The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil
Hisrael Passarelli-Araujo, Henrique Pott-Junior, Aline M. Susuki,…Michael Aschner, Monica M.B. Paoliello, Mariana R. Urbano
Published online: February 19, 2022
p491-496

Influenza vaccination coverage among adults by nativity, race/ethnicity, citizenship, and language of the interview – United States, 2012-2013 through 2017-2018 influenza seasons

American Journal of Infection Control
May 2022 Volume 50 Issue 5 p477-592
http://www.ajicjournal.org/current

 

Influenza vaccination coverage among adults by nativity, race/ethnicity, citizenship, and language of the interview – United States, 2012-2013 through 2017-2018 influenza seasons
Meagan R. Chuey, Mei-Chuan Hung, Anup Srivastav,…Kimberly H. Nguyen, Walter W. Williams, Alfonso Rodriguez Lainz
Published online: September 11, 2021
p497-502

Mask use among health care workers and feelings of safety at work pre- and post- COVID-19 vaccine

American Journal of Infection Control
May 2022 Volume 50 Issue 5 p477-592
http://www.ajicjournal.org/current

 

Mask use among health care workers and feelings of safety at work pre- and post- COVID-19 vaccine
Laura S. O’Donohue, Susan Fletcher-Gutowski, Amreetpal Sidhu, Aishwarya Verma, Tarin C. Phillips,
Preeti G. Misra
Published online: November 15, 2021
p503-508

Racial and ethnic differences in vaccine hesitancy Among registered nurses in New Jersey: A cross-sectional survey

American Journal of Infection Control
May 2022 Volume 50 Issue 5 p477-592
http://www.ajicjournal.org/current

 

Brief Reports
Racial and ethnic differences in vaccine hesitancy Among registered nurses in New Jersey: A cross-sectional survey
Irina B. Grafova, Monika Pogorzelska-Maziarz, Mary L. Johansen, Mary Lou Manning, Suzanne Crincoli,
Pamela B. de Cordova
Published online: February 11, 2022
p572-574

COVID-19 Vaccine Uptake Among Nursing Home Staff via Statewide Policy: The Mississippi Vaccinate or Test Out Policy

American Journal of Public Health
May 2022 112(5)
http://ajph.aphapublications.org/toc/ajph/current

 

Articles
COVID-19 Vaccine Uptake Among Nursing Home Staff via Statewide Policy: The Mississippi Vaccinate or Test Out Policy
Immunization/Vaccines, Health Policy, Aging
Maggie L. Syme, Natalia Gouskova and Sarah D. Berry

Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points

Annals of Internal Medicine
May 2022 Volume 175, Issue 5
http://annals.org/aim/issue

 

Reviews
Major Update 2: Remdesivir for Adults With COVID-19: A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points
FREE
Anjum S. Kaka, MD, Roderick MacDonald, MS, Eric J. Linskens, BS, Lisa Langsetmo, PhD, … et al.
Pages:701–709

Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 21 May 2022)

 

Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study
Iran had a high rate of death in several COVID 19 waves. Vaccination is a method for prevention and control of the COVID-19 pandemic. Success in controlling the pandemic is not solely dependent on the effectiv…
Authors: Shabnam Omidvar and Mojgan Firouzbakht
Citation: BMC Health Services Research 2022 22:652
Content type: Research Published on: 16 May 2022

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 21 May 2022)

 

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru
This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a hexavale…
Authors: Janice Seinfeld, María Laura Rosales, Alfredo Sobrevilla and Juan Guillermo López Yescas
Citation: BMC Health Services Research 2022 22:651
Content type: Research Published on: 16 May 2022

Testing and vaccination to reduce the impact of COVID-19 in nursing homes: an agent-based approach

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 21 May 2022)

 

Testing and vaccination to reduce the impact of COVID-19 in nursing homes: an agent-based approach
Efforts to protect residents in nursing homes involve non-pharmaceutical interventions, testing, and vaccine. We sought to quantify the effect of testing and vaccine strategies on the attack rate, length of th…
Authors: José P. Gómez Vázquez, Yury E. García, Alec J. Schmidt, Beatriz Martínez-López and Miriam Nuño
Citation: BMC Infectious Diseases 2022 22:477
Content type: Research Published on: 19 May 2022

Adverse effects following COVID-19 vaccination in Iran

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 21 May 2022)

 

Adverse effects following COVID-19 vaccination in Iran
Vaccination is a key intervention to prevent COVID-19. Many vaccines are administered globally, yet there is not much evidence regarding their safety and adverse effects. Iran also faces this challenge, especi…
Authors: Ebrahim Babaee, Ali Amirkafi, Arash Tehrani-Banihashemi, Neda SoleimanvandiAzar, Babak Eshrati, Zahra Rampisheh, Mehran Asadi-Aliabadi and Marzieh Nojomi
Citation: BMC Infectious Diseases 2022 22:476
Content type: Research Published on: 18 May 2022

Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 21 May 2022)

 

Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey
Vaccination has been proven to be an effective approach against the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the acceptance rate and factors influencing acceptance of COVID-1…
Authors: Jinming Su, Zhenwei Jia, Xinwei Wang, Fengxiang Qin, Rongfeng Chen, Yuting Wu, Beibei Lu, Chunlin Lan, Tongxue Qin, Yinlu Liao, Minjuan Shi, Yanyan Liao, Peijiang Pan, Li Ye, Junjun Jiang and Hao Liang
Citation: BMC Infectious Diseases 2022 22:471
Content type: Research Published on: 16 May 2022

Patient consent preferences on sharing personal health information during the COVID-19 pandemic: “the more informed we are, the more likely we are to help”

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 21 May 2022)

 

Patient consent preferences on sharing personal health information during the COVID-19 pandemic: “the more informed we are, the more likely we are to help”
Authors: Sarah Tosoni, Indu Voruganti, Katherine Lajkosz, Shahbano Mustafa, Anne Phillips, S. Joseph Kim, Rebecca K. S. Wong, Donald Willison, Carl Virtanen, Ann Heesters and Fei-Fei Liu
Content type: Research 20 May 2022

An assessment of the vaccination of school-aged children in England against SARS-CoV-2

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 21 May 2022)

 

An assessment of the vaccination of school-aged children in England against SARS-CoV-2
Children and young persons are known to have a high number of close interactions, often within the school environment, which can facilitate rapid spread of infection; yet for SARS-CoV-2, it is the elderly and …
Authors: Matt J. Keeling and Sam E. Moore
Citation: BMC Medicine 2022 20:196
Content type: Research article Published on: 18 May 2022

Perceptions of the Coronavirus and COVID-19 testing and vaccination in Latinx and Indigenous Mexican immigrant communities in the Eastern Coachella Valley

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 21 May 2022)

 

Perceptions of the Coronavirus and COVID-19 testing and vaccination in Latinx and Indigenous Mexican immigrant communities in the Eastern Coachella Valley
A novel coronavirus, SARS-CoV-2 (known as COVID-19), spread rapidly around the world, affecting all and creating an ongoing global pandemic. Across the United States, Latinx and Indigenous populations have bee…
Authors: Daniel Gehlbach, Evelyn Vázquez, Gabriela Ortiz, Erica Li, Cintya Beltrán Sánchez, Sonia Rodríguez, María Pozar and Ann M. Cheney
Citation: BMC Public Health 2022 22:1019
Content type: Research Published on: 21 May 2022

Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020–2021: situational analysis

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 21 May 2022)

 

Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020–2021: situational analysis
The COVID-19 pandemic had a colossal impact on human society globally. There were similarities and differences in the public health and social measures taken by countries, and comparative analysis facilitates …
Authors: Noriko Kitamura, Kaja Abbas and Dilip Nathwani
Citation: BMC Public Health 2022 22:991
Content type: Research Published on: 17 May 2022

Trinity review: integrating Registered Reports with research ethics and funding reviews

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 21 May 2022)

 

Trinity review: integrating Registered Reports with research ethics and funding reviews
One major source of exhaustion for researchers is the redundant paperwork of three different documents—research papers, ethics review applications, and research grant applications—for the same research plan. T…
Authors: Yuki Mori, Kaito Takashima, Kohei Ueda, Kyoshiro Sasaki and Yuki Yamada
Citation: BMC Research Notes 2022 15:184
Content type: Commentary Published on: 19 May 2022
Abstract
One major source of exhaustion for researchers is the redundant paperwork of three different documents—research papers, ethics review applications, and research grant applications—for the same research plan. This is a wasteful and redundant process for researchers, and it has a more direct impact on the career development of early-career researchers. Here, we propose a trinity review system based on Registered Reports that integrates scientific, ethics, and research funding reviews. In our proposed trinity review system, scientific and ethics reviews are undertaken concurrently for a research protocol before running the study. After the protocol is approved in principle through these review processes, a funding review will take place, and the researchers will begin their research. Following the experiments or surveys, the scientific review will be conducted on a completed version of the paper again, including the results and discussions (i.e., the full paper), and the full paper will be published once it has passed the second review. This paper provides the brief process of the trinity review system and discusses the need for and benefits of the proposed system. Although the trinity review system only applies to a few appropriate disciplines, it helps improve reproducibility and integrity.

Improving research integrity: a framework for responsible science communication

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 21 May 2022)

 

Improving research integrity: a framework for responsible science communication
Research integrity, an essential precept of scientific inquiry and discovery, comprises norms such as Rigor, Reproducibility, and Responsibility (the 3R’s). Over the past decades, numerous issues have arisen that challenge the reliability of scientific studies, including irreproducibility crises, lack of good scientific principles, and erroneous communications, which have impacted the public’s trust in science and its findings. Here, we highlight one important component of research integrity that is often overlooked in the discussion of proposals for improving research quality and promoting robust research; one that spans from the lab bench to the dissemination of scientific work: responsible science communication.
Authors: Ilinca I. Ciubotariu and Gundula Bosch
Citation: BMC Research Notes 2022 15:177
Content type: Commentary Published on: 15 May 2022

Precision medicine requires understanding how both sex and gender influence health

Cell
May 12, 2022 Volume 185 Issue 10 p1619-1806
https://www.cell.com/cell/current

 

Commentary
Precision medicine requires understanding how both sex and gender influence health
Nina S. Stachenfeld, Carolyn M. Mazure
Progress in studying sex as a biological variable (SABV) is slow, and the influence of gendered effects of the social environment on biology is largely unknown. Yet incorporating these concepts into basic science research will enhance our understanding human health and disease. We provide steps to move this process forward.

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 21 May 2022]

 

COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
Safety data reported from the large-scale clinical trials of the coronavirus disease 2019 (COVID-19) vaccine are extremely limited in patients with decompensated cirrhosis. The vaccination campaign in this spe…
Authors: Zhujun Cao, Chenxi Zhang, Shuang Zhao, Zike Sheng, Xiaogang Xiang, Ruokun Li, Zhuping Qian, Yinling Wang, Bin Chen, Ziqiang Li, Yuhan Liu, Baoyan An, Huijuan Zhou, Wei Cai, Hui Wang, Honglian Gui…
Citation: Infectious Diseases of Poverty 2022 11:56
Content type: Research Article Published on: 16 May 2022

Could China’s journey of malaria elimination extend to Africa?

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 21 May 2022]

 

Could China’s journey of malaria elimination extend to Africa?
World Health Organization (WHO) certified China malaria-free on June 30, 2021, which brightens the goal of global malaria elimination efforts. China contributed its unique innovations to the global community: …
Authors: Duoquan Wang, Shan Lv, Wei Ding, Shenning Lu, Hongwei Zhang, Kokouvi Kassegne, Shang Xia, Lei Duan, Xuejiao Ma, Lulu Huang, Roly Gosling, Joshua Levens, Salim Abdulla, Mutinta Mudenda, Moses Okpeku, Kenneth Kamwi Matengu…
Citation: Infectious Diseases of Poverty 2022 11:55
Content type: Opinion Published on: 16 May 2022

The impact of pertussis vaccine programme changes on pertussis disease burden in Manitoba, 1992–2017—an age-period-cohort analysis

International Journal of Epidemiology
Volume 51, Issue 2, April 2022
https://academic.oup.com/ije/issue

 

Infectious Disease
The impact of pertussis vaccine programme changes on pertussis disease burden in Manitoba, 1992–2017—an age-period-cohort analysis
Krista Wilkinson, Christiaan H Righolt, Lawrence J Elliott, Sergio Fanella, Salaheddin M Mahmud
International Journal of Epidemiology, Volume 51, Issue 2, April 2022, Pages 440–447, https://doi.org/10.1093/ije/dyac001

Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021

JAMA
May 17, 2022, Vol 327, No. 19, Pages 1849-1936
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021
Giovanni Nattino, PhD; Sara Castiglioni, PhD; Danilo Cereda, MD, PhD; et al.
free access
JAMA. 2022;327(19):1922-1924. doi:10.1001/jama.2022.4908
This study evaluates the association between SARS-CoV-2 load in urban wastewater and surveillance indicators of infection prevalence and severity in Milan, Italy.

Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical ResearchThe PRO Ethics Guidelines

JAMA
May 17, 2022, Vol 327, No. 19, Pages 1849-1936
https://jamanetwork.com/journals/jama/currentissue

 

Special Communication
Ethical Considerations for the Inclusion of Patient-Reported Outcomes in Clinical ResearchThe PRO Ethics Guidelines
Samantha Cruz Rivera, PhD; Olalekan Lee Aiyegbusi, PhD; Jonathan Ives, PhD; et al.
free access has active quiz has audio
JAMA. 2022;327(19):1910-1919. doi:10.1001/jama.2022.6421
These international, consensus-based, patient-reported outcomes (PRO)–specific guidelines aim to lay out the ethical considerations that researchers, research ethics committees, and funders should take into account when conducting or reviewing PRO clinical research.

COVID-19 Vaccination—Becoming Part of the New Normal

JAMA
May 17, 2022, Vol 327, No. 19, Pages 1849-1936
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
COVID-19 Vaccination—Becoming Part of the New Normal
Peter Marks, MD, PhD; Janet Woodcock, MD; Robert Califf, MD
free access
JAMA. 2022;327(19):1863-1864. doi:10.1001/jama.2022.7469
In this Viewpoint, authors from the FDA discuss how COVID-19 vaccination is an integral part of establishing a new normal, now that SARS-CoV-2, the virus that causes COVID-19, will likely circulate worldwide for the foreseeable future.

Willingness of a Multiethnic Immigrant Population to Donate Biospecimens for Research Purposes

Journal of Immigrant and Minority Health
Volume 24, issue 3, June 2022
https://link.springer.com/journal/10903/volumes-and-issues/24-3

 

Contents
Willingness of a Multiethnic Immigrant Population to Donate Biospecimens for Research Purposes
Authors (first, second and last of 12)
Amy Raines-Milenkov, Martha Felini, Jonathan Hughes
Content type: Original Paper
Open Access
Published: 26 July 2021
Pages: 705 – 712

Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample

Journal of Immigrant and Minority Health
Volume 24, issue 3, June 2022
https://link.springer.com/journal/10903/volumes-and-issues/24-3

 

Nativity Differences in Awareness and Knowledge About HPV Infection and Vaccination Among U.S. Adults: Findings from a National Population-Based Sample
Authors
Manami Bhattacharya, Serena Xiong, Annie-Laurie McRee
Content type: Brief Communication
Published: 28 August 2021
Pages: 794 – 798

Introduction to Special Issue: Gender, Migration and Digital Communication in Asia

Journal of Immigrant & Refugee Studies
Volume 20, 2022 Issue 2
https://www.tandfonline.com/toc/wimm20/current

 

Article
Introduction to Special Issue: Gender, Migration and Digital Communication in Asia
Shiori Shakuto & Brenda S. A. Yeoh
Pages: 155-163
Published online: 15 Apr 2022
Abstract
In recent decades, the role of digital communication in the lives of migrants in Asia has greatly expanded, becoming integral to the decision to migrate, earning a living, and the practice of keeping in touch with left-behind families and friends. The papers in this Special Issue foreground how gender structures and practices within migrant households and the wider political economy shape migrants’ digital communications. They expand the breadth of our thinking about the interlinkages among gender, migration and digital communication from a range of new subject positions including transnational families, international students, and marginalized minorities in the region.

The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 VariantsGet access

Journal of Infectious Diseases
Volume 225, Issue 6, 15 March 2022
https://academic.oup.com/jid/issue/225/6

 

PERSPECTIVES
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 VariantsGet access
Abie Rohrig, Nir Eyal
The Journal of Infectious Diseases, Volume 225, Issue 6, 15 March 2022, Pages 934–937, https://doi.org/10.1093/infdis/jiab488
Researchers are preparing for human challenge trials with emerging SARS-CoV-2 variants. We argue that these trials can be ethical.

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

The Lancet
May 21, 2022 Volume 399 Number 10339 p1917-1990
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
WHO Solidarity Trial Consortium
Open Access
Background
The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir, hydroxychloroquine, and interferon (IFN)-β1a were discontinued for futility but randomisation to remdesivir continued. Here, we report the final results of Solidarity and meta-analyses of mortality in all relevant trials to date.
Interpretation
Remdesivir has no significant effect on patients with COVID-19 who are already being ventilated. Among other hospitalised patients, it has a small effect against death or progression to ventilation (or both).

Framing and the formation of global health priorities

The Lancet
May 21, 2022 Volume 399 Number 10339 p1917-1990
https://www.thelancet.com/journals/lancet/issue/current

 

Series
Political Science and Health
Framing and the formation of global health priorities
Jeremy Shiffman, Yusra Ribhi Shawar
Summary
Health issues vary in the amount of attention and resources they receive from global health organisations and national governments. How issues are framed could shape differences in levels of priority. We reviewed scholarship on global health policy making to examine the role of framing in shaping global health priorities. The review provides evidence of the influence of three framing processes—securitisation, moralisation, and technification. Securitisation refers to an issue’s framing as an existential threat, moralisation as an ethical imperative, and technification as a wise investment that science can solve. These framing processes concern more than how issues are portrayed publicly. They are socio-political processes, characterised by contestation among actors in civil society, government, international organisations, foundations, and research institutions. These actors deploy various forms of power to advance particular frames as a means of securing attention and resources for the issues that concern them. The ascription of an issue as a security concern, an ethical imperative, or a wise investment is historically contingent: it is not inevitable that any given issue will be framed in one or more of these ways. A health issue’s inherent characteristics—such as the lethality of a pathogen that causes it—also shape these ascriptions, but do not fully determine them. Although commonly facing resistance, global health elites often determine which frames prevail, raising questions about the legitimacy of priority-setting processes. We draw on the review to offer ideas on how to make these processes fairer than they are at present, including a call for democratic representation even as necessary space is preserved for elite expertise.

Polygenic risk scores for CARDINAL study

Nature Genetics
Volume 54 Issue 5, May 2022
https://www.nature.com/ng/volumes/54/issues/4

 

Comment | 05 May 2022
Polygenic risk scores for CARDINAL study
The Cardiometabolic Disorders in African-Ancestry Populations (CARDINAL) study site is a well-powered, first-of-its-kind resource for developing, refining and validating methods for research into polygenic risk scores that accounts for local ancestry, to improve risk prediction in diverse populations.
Clement A. Adebamowo, Adebowale Adeyemo, Sally N. Adebamowo

Promoting the genomic revolution in Africa through the Nigerian 100K Genome Project

Nature Genetics
Volume 54 Issue 5, May 2022
https://www.nature.com/ng/volumes/54/issues/4

 

Comment | 09 May 2022
Promoting the genomic revolution in Africa through the Nigerian 100K Genome Project
To leverage the genetic diversity in Nigeria, we established the Non-Communicable Diseases Genetic Heritage Study (NCD-GHS) consortium to help produce a comprehensive catalog of human genetic variation in Nigeria and assess the burden and etiological characteristics of non-communicable diseases in 100,000 adults in Nigeria.
Segun Fatumo, Aminu Yakubu, Abasi Ene-Obong